Cardiome Pharma reports record revenues in second quarter 2014 Cardiome Pharma Corp.

today reported financial results for the next quarter and half a year ended June 30, 2014. Amounts, unless specified normally, are expressed in U.S. Dollars and in accordance with generally accepted accounting principles used in the United States of America . On April 12 All talk about and per share amounts reflect the one-for-five talk about consolidation that happened, 2013. Cardiome's financial outcomes for the second quarter and first six months of 2014 are on the right track with our plan, stated William Hunter, M.D., Cardiome's CEO and president.‘However, it’s been shown over and over that the nerve cells produced by the transplant hardly migrate into the mind but remain generally confined to the implant site,’ says Prof. Dr. Researchers have thought for a long period that effect is linked to the reality that in the mature mind, there are unfavorable circumstances for the uptake of extra nerve cells. Immature and older nerve cells attract one another like magnets The experts from the Institute for Reconstructive Neurobiology of Bonn University have finally discovered a completely unexpected mechanism to that your deficient migratory behavior of the graft-derived neurons could be attributed. The implanted cells mature at different rates and there’s a mixture of both stages thus.